mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
4e-15 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-14 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
1e-10 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-10 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.3 |
5e-06 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |